Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C25H27ClN2O.2ClH |
| Molecular Weight | 479.87 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.OC(CN1CCN(CC1)C2=CC=CC(Cl)=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=WPEXRXMQMPOHIO-UHFFFAOYSA-N
InChI=1S/C25H27ClN2O.2ClH/c26-22-12-7-13-23(18-22)28-16-14-27(15-17-28)19-24(29)25(20-8-3-1-4-9-20)21-10-5-2-6-11-21;;/h1-13,18,24-25,29H,14-17,19H2;2*1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C25H27ClN2O |
| Molecular Weight | 406.948 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9303567Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11750791
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9303567
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11750791
BRL-15572 is a 5-HT1D receptor antagonist with pKi of 7.9, also shows a considerable affinity at 5-HT1A and 5-HT2B receptors, exhibiting 60-fold selectivity over 5-HT1B receptor.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11750791 | http://www.abcam.com/brl-15572-monohydrochloride-ab120517.html
Curator's Comment: brain penetrant
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1983 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9303567 |
7.9 null [pKi] | ||
Target ID: CHEMBL214 |
7.7 null [pKi] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17880377
bolus i.v. administration, 1 mg/kg
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11172936
Antagonism of all three 5-HT autoreceptors with BRL-15572 (100 nM) significantly increased 5-HT effux in the rat dorsal raphe nucleus
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:41:02 GMT 2025
by
admin
on
Wed Apr 02 08:41:02 GMT 2025
|
| Record UNII |
X83G4TN8JZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
64060
Created by
admin on Wed Apr 02 08:41:02 GMT 2025 , Edited by admin on Wed Apr 02 08:41:02 GMT 2025
|
PRIMARY | |||
|
193611-72-2
Created by
admin on Wed Apr 02 08:41:02 GMT 2025 , Edited by admin on Wed Apr 02 08:41:02 GMT 2025
|
PRIMARY | |||
|
DTXSID70872473
Created by
admin on Wed Apr 02 08:41:02 GMT 2025 , Edited by admin on Wed Apr 02 08:41:02 GMT 2025
|
PRIMARY | |||
|
X83G4TN8JZ
Created by
admin on Wed Apr 02 08:41:02 GMT 2025 , Edited by admin on Wed Apr 02 08:41:02 GMT 2025
|
PRIMARY | |||
|
9891303
Created by
admin on Wed Apr 02 08:41:02 GMT 2025 , Edited by admin on Wed Apr 02 08:41:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|